<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2604-1227</journal-id>
<journal-title><![CDATA[Revista mexicana de oftalmología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. oftalmol]]></abbrev-journal-title>
<issn>2604-1227</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Oftalmología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2604-12272021000500215</article-id>
<article-id pub-id-type="doi">10.24875/rmo.m21000156</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Coroiditis por hipersensibilidad secundaria a tuberculosis ocular inactiva. Reporte de un caso]]></article-title>
<article-title xml:lang="en"><![CDATA[Choroiditis due to hypersensitivity secondary to inactive ocular tuberculosis. Case report]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Echevarría-Lucas]]></surname>
<given-names><![CDATA[Lucía]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Góngora-Miñarro]]></surname>
<given-names><![CDATA[M. Mar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gómez-Cabrera]]></surname>
<given-names><![CDATA[Cristina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jódar-Márquez]]></surname>
<given-names><![CDATA[Margarita]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gómez-Fernández]]></surname>
<given-names><![CDATA[Juan J.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Comarcal de la Axarquía Servicio de Oftalmología ]]></institution>
<addr-line><![CDATA[Málaga ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Regional Universitario Servicio de Oftalmología ]]></institution>
<addr-line><![CDATA[Málaga ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2021</year>
</pub-date>
<volume>95</volume>
<numero>5</numero>
<fpage>215</fpage>
<lpage>221</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2604-12272021000500215&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2604-12272021000500215&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2604-12272021000500215&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: Describir que el ojo, ante procesos infecciosos sistémicos diversos que afectan a sus estructuras, tales como tuberculosis, infección por virus Ébola o sida (con sus infecciones oportunistas), una vez curado de su fase activa infecciosa reacciona de manera similar.  Caso clínico: Presentamos el caso de una paciente que, tras ser tratada con éxito de tuberculosis ocular, desarrolló una coroiditis multifocal por hipersensibilidad retardada, de efectos potencialmente más devastadores que la propia infección activa, con inflamación coroidea y de vasos retinianos, papilitis y edema macular que, sin tratamiento, conduciría a una gran pérdida visual. Para su control, precisó corticoides sistémicos a corto plazo e inmunosupresores sistémicos de mantenimiento a largo plazo.  Conclusiones: Las reacciones inflamatorias oculares por hipersensibilidad son más destructivas que la infección directa de diversos patógenos, ya que pueden generar una reacción inflamatoria basada en el reconocimiento del sistema inmunitario de restos antigénicos infecciosos en las estructuras oculares. Comprobar el control de la infección activa y posteriormente introducir corticoides sistémicos o inmunosupresores ahorradores de corticoides tiene efectos muy beneficiosos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Purpose: To describe that the eye, after healing its active infectious stage, reacts similarly against several systemic infectious processes that affect its structures, such as tuberculosis, Ebola, or AIDS (together with its opportunist infections).  Case report: We report the case of a female patient that, after a successful treatment against ocular tuberculosis, developed a multifocal choroiditis due to delayed hypersensitivity, with more potential devastating effects than the active infection itself: inflammation of choroidal and retinal vessels, papillitis, and macular edema that, without treatment, may induce severe visual loss. The patient received short-term systemic corticosteroids and long-term maintenance with systemic immunosuppressants.  Conclusions: Ocular inflammatory reactions due to hypersensitivity are more destructive than the direct infection by different pathogens since there may be an inflammatory reaction secondary to the immune recognition of infectious antigenic particles in the ocular structures. Treatment is based on verifying that the active infection has been controlled and, subsequently, initiating systemic corticoids or corticosteroid-sparing immunosuppressive agents.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Coroiditis por hipersensibilidad]]></kwd>
<kwd lng="es"><![CDATA[Tuberculosis ocular]]></kwd>
<kwd lng="es"><![CDATA[Síndrome de recuperación inmunitaria]]></kwd>
<kwd lng="es"><![CDATA[Inmunosupresores]]></kwd>
<kwd lng="en"><![CDATA[Choroiditis due to hypersensitivity]]></kwd>
<kwd lng="en"><![CDATA[Ocular tuberculosis]]></kwd>
<kwd lng="en"><![CDATA[Immune reconstitution syndrome]]></kwd>
<kwd lng="en"><![CDATA[Immunosuppressants]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shakarchi]]></surname>
<given-names><![CDATA[FI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ocular tuberculosis:current perspectives]]></article-title>
<source><![CDATA[Clin Ophthalmol Auckl NZ]]></source>
<year>2015</year>
<volume>9</volume>
<page-range>2223-7</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adán Civera]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Avances en el diagnóstico y tratamiento de las infecciones intraoculares]]></article-title>
<source><![CDATA[Monografías de la Sociedad Española de Oftalmología]]></source>
<year>2012</year>
<page-range>168</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tenorio-Guajardo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez-Casanova]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[González-Rodríguez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tuberculosis ocular. Serie de casos en el Hospital General de México]]></article-title>
<source><![CDATA[Rev Médica Hosp Gen México]]></source>
<year>2014</year>
<volume>77</volume>
<page-range>17-23</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shantha]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Crozier]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Yeh]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An update on ocular complications of Ebola virus disease]]></article-title>
<source><![CDATA[Curr Opin Ophthalmol]]></source>
<year>2017</year>
<volume>28</volume>
<page-range>600-6</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shantha]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Mattia]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Goba]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Barnes]]></surname>
<given-names><![CDATA[KG]]></given-names>
</name>
<name>
<surname><![CDATA[Ebrahim]]></surname>
<given-names><![CDATA[FK]]></given-names>
</name>
<name>
<surname><![CDATA[Kraft]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study:reverse transcription-polymerase chain reaction and cataract surgery outcomes of Ebola survivors in Sierra Leone]]></article-title>
<source><![CDATA[EBioMedicine]]></source>
<year>2018</year>
<volume>30</volume>
<page-range>217-24</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ganesh]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Abraham]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sudharshan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Paradoxical reactions in ocular tuberculosis]]></article-title>
<source><![CDATA[J Ophthalmic Inflamm Infect]]></source>
<year>2019</year>
<volume>9</volume>
<page-range>19</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Robinson]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Reed]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Csaky]]></surname>
<given-names><![CDATA[KG]]></given-names>
</name>
<name>
<surname><![CDATA[Polis]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Whitcup]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy]]></article-title>
<source><![CDATA[Am J Ophthalmol]]></source>
<year>2000</year>
<volume>130</volume>
<page-range>49-56</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[M-K]]></given-names>
</name>
<name>
<surname><![CDATA[Azen]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Buley]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Torriani]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Cheng]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Chaidhawangul]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis]]></article-title>
<source><![CDATA[Am J Ophthalmol]]></source>
<year>2003</year>
<volume>136</volume>
<page-range>696-702</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Concha del Río]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Garza León]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[González Rubio Medina]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Recillas Gispert]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Voorduin Ramos]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz Cruz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guías mexicanas para el manejo de uveítis no infecciosa en adultos]]></article-title>
<source><![CDATA[Centro Mexicano de Enfermedades Inflamatorias Oculares (CMEIO)]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<collab>Red Nacional de Vigilancia Epidemiológica</collab>
<source><![CDATA[Protocolo de vigilancia y alerta de tuberculosis]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Sevilla ]]></publisher-loc>
<publisher-name><![CDATA[Junta de Andalucía]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Echevarría Lucas]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Medialdea Hurtado]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Villena Irigoyen]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[De Ramón Garrido]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Granuloma tuberculoso macular asociado a membrana neovascular tratado con terapia anti-factor de crecimiento endotelial vascular]]></article-title>
<source><![CDATA[Archivos de la Sociedad Canaria de Oftalmología]]></source>
<year>2018</year>
<volume>29</volume>
<page-range>77-83</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cano]]></surname>
<given-names><![CDATA[Parra J]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz-Llopis]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drug induced uveitis]]></article-title>
<source><![CDATA[Arch Soc Esp Oftalmol]]></source>
<year>2005</year>
<volume>80</volume>
<page-range>137-49</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Julián]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[¿TB or not TB?El dilema de la uveítis asociada a tuberculosis]]></article-title>
<source><![CDATA[Oftalmol Clin Exp]]></source>
<year>2013</year>
<volume>6</volume>
<page-range>35-44</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz-Cruz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarado de la Barrera]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ablanedo Terrazas]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes Terán]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Proposed clinical definition for cytomegalovirus-immune recovery retinitis]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2014</year>
<volume>59</volume>
<page-range>298-303</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
